TY - STD TI - Howlader N, Noone AM, Krapcho M, Garshell J, Miller D, Altekruse SF, et al. SEER Cancer Statistics Review, 1975–2012, National Cancer Institute. Bethesda, MD, http://seer.cancer.gov/csr/1975_2012/, based on November 2014 SEER data submission, posted to the SEER web site, April 2015 ID - ref1 ER - TY - JOUR AU - Chen, Y. AU - Wang, J. AU - Fraig, M. M. AU - Henderson, K. AU - Bissada, N. K. AU - Watson, D. K. PY - 2003 DA - 2003// TI - Alterations in PMS2, MSH2 and MLH1 expression in human prostate cancer JO - Int J Oncol VL - 22 ID - Chen2003 ER - TY - JOUR AU - Roupret, M. AU - Yates, D. R. AU - Comperat, E. AU - Cussenot, O. PY - 2008 DA - 2008// TI - Upper urinary tract urothelial cell carcinomas and other urological malignancies involved in the hereditary nonpolyposis colorectal cancer (Lynch Syndrome) tumour spectrum JO - Eur Urol VL - 54 UR - https://doi.org/10.1016/j.eururo.2008.08.008 DO - 10.1016/j.eururo.2008.08.008 ID - Roupret2008 ER - TY - JOUR AU - Ryan, S. AU - Jenkins, M. A. AU - Win, A. K. PY - 2014 DA - 2014// TI - Risk of prostate cancer in Lynch syndrome: a systematic review and meta-analysis JO - Cancer Epidemiol Biomarkers Prev VL - 23 UR - https://doi.org/10.1158/1055-9965.EPI-13-1165 DO - 10.1158/1055-9965.EPI-13-1165 ID - Ryan2014 ER - TY - JOUR AU - Castro, E. AU - Goh, C. L. AU - Eeles, R. A. PY - 2013 DA - 2013// TI - Prostate cancer screening in BRCA and Lynch syndrome mutation carriers JO - Am Soc Clin Oncol Educ Book ID - Castro2013 ER - TY - JOUR AU - Bacher, J. W. AU - Flanagan, L. A. AU - Smalley, R. L. AU - Nassif, N. A. AU - Burgart, L. J. AU - Halberg, R. B. PY - 2004 DA - 2004// TI - Development of a fluorescent multiplex assay for detection of MSI-High tumors JO - Dis Markers VL - 20 UR - https://doi.org/10.1155/2004/136734 DO - 10.1155/2004/136734 ID - Bacher2004 ER - TY - JOUR AU - Bancroft, E. K. AU - Page, E. C. AU - Castro, E. AU - Lilja, H. AU - Vickers, A. AU - Sjoberg, D. PY - 2014 DA - 2014// TI - Targeted Prostate Cancer Screening in BRCA1 and BRCA2 Mutation Carriers: Results from the Initial Screening Round of the IMPACT Study JO - Eur Urol VL - 66 UR - https://doi.org/10.1016/j.eururo.2014.01.003 DO - 10.1016/j.eururo.2014.01.003 ID - Bancroft2014 ER - TY - JOUR AU - Alexandrov, L. B. AU - Nik-Zainal, S. AU - Wedge, D. C. AU - Aparicio, S. A. AU - Behjati, S. AU - Biankin, A. V. PY - 2013 DA - 2013// TI - Signatures of mutational processes in human cancer JO - Nature VL - 500 UR - https://doi.org/10.1038/nature12477 DO - 10.1038/nature12477 ID - Alexandrov2013 ER - TY - JOUR AU - Raymond, V. M. AU - Mukherjee, B. AU - Wang, F. AU - Huang, S. C. AU - Stoffel, E. M. AU - Kastrinos, F. PY - 2013 DA - 2013// TI - Elevated risk of prostate cancer among men with Lynch syndrome JO - J Clin Oncol VL - 31 UR - https://doi.org/10.1200/JCO.2012.44.1238 DO - 10.1200/JCO.2012.44.1238 ID - Raymond2013 ER - TY - JOUR AU - Win, A. K. AU - Young, J. P. AU - Lindor, N. M. AU - Tucker, K. M. AU - Ahnen, D. J. AU - Young, G. P. PY - 2012 DA - 2012// TI - Colorectal and other cancer risks for carriers and non carriers from families with a DNA mismatch repair gene mutation: a prospective cohort study JO - J Clin Oncol VL - 30 UR - https://doi.org/10.1200/JCO.2011.39.5590 DO - 10.1200/JCO.2011.39.5590 ID - Win2012 ER - TY - JOUR AU - Bratt, O. PY - 2000 DA - 2000// TI - Hereditary prostate cancer JO - BJU Int VL - 85 UR - https://doi.org/10.1046/j.1464-410x.2000.00457.x DO - 10.1046/j.1464-410x.2000.00457.x ID - Bratt2000 ER - TY - JOUR AU - Grindedal, E. M. AU - Moller, P. AU - Eeles, R. AU - Stormorken, A. T. AU - Bowitz-Lothe, I. M. AU - Landrø, S. M. PY - 2009 DA - 2009// TI - Germ-line mutations in mismatch repair genes associated with prostate cancer JO - Cancer Epidemiol Biomarkers Prev VL - 18 UR - https://doi.org/10.1158/1055-9965.EPI-09-0058 DO - 10.1158/1055-9965.EPI-09-0058 ID - Grindedal2009 ER - TY - JOUR AU - Wang, Q. AU - Zhang, H. AU - Guerrette, S. AU - Chen, J. AU - Mazurek, A. AU - Wilson, T. PY - 2001 DA - 2001// TI - Adenosine nucleotide modulates the physical interaction between hMSH2 and BRCA1 JO - Oncogene VL - 20 UR - https://doi.org/10.1038/sj.onc.1204625 DO - 10.1038/sj.onc.1204625 ID - Wang2001 ER - TY - JOUR AU - Peng, M. AU - Xie, J. AU - Ucher, A. AU - Stavnezer, J. AU - Cantor, S. B. PY - 2014 DA - 2014// TI - Crosstalk between BRCA-Fanconi anemia and mismatch repair pathways prevents MSH2-dependent aberrant DNA damage responses JO - EMBO J VL - 33 UR - https://doi.org/10.15252/embj.201387530 DO - 10.15252/embj.201387530 ID - Peng2014 ER - TY - JOUR AU - Castro, E. AU - Goh, C. AU - Leongamornlert, D. AU - Saunders, E. AU - Tymrakiewicz, M. AU - Dadaev, T. PY - 2015 DA - 2015// TI - Effect of BRCA mutations on metastatic relapse and cause-specific survival after radical treatment for localised prostate cancer JO - Eur Urol VL - 68 UR - https://doi.org/10.1016/j.eururo.2014.10.022 DO - 10.1016/j.eururo.2014.10.022 ID - Castro2015 ER - TY - JOUR AU - Rosty, C. AU - Walsh, M. D. AU - Lindor, N. M. AU - Thibodeau, S. N. AU - Mundt, E. AU - Gallinger, S. PY - 2014 DA - 2014// TI - High prevalence of mismatch repair deficiency in prostate cancers diagnosed in mismatch repair gene mutation carriers from the colon cancer family registry JO - Familial Cancer VL - 13 UR - https://doi.org/10.1007/s10689-014-9744-1 DO - 10.1007/s10689-014-9744-1 ID - Rosty2014 ER -